Pancreatic Cancer Research

ResearcherUniversity of Colorado AnschutzActive in the last 2 years

Shuichi Watanabe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0170-4937; OpenAlex author ID A5074475264. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
65
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper

Papers 10

  1. Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study. Co-author DOI 10.1200/jco.23.02313↗
  2. Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2022.12.039↗
  3. Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. Co-author DOI 10.1111/cas.15615↗
  4. RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer. Co-author DOI 10.3892/ijo.2023.5499↗
  5. Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-21-2767↗
  6. C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. Co-author DOI 10.1038/s41598-021-89530-8↗
  7. Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection. Co-author DOI 10.1371/journal.pone.0249885↗
  8. Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology. Co-author DOI 10.21037/jgo-21-119↗
  9. Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting fo… Co-author DOI 10.1186/s40792-020-01082-7↗
  10. Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality. Co-author DOI 10.1002/ijc.32072↗

Closest collaborators

The 25 strongest of 65 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroaki Ono · 6 shared papers, 2019–2023 · strength 0.73
  2. Kosuke Ogawa · 6 shared papers, 2019–2023 · strength 0.73
  3. Minoru Tanabe · 6 shared papers, 2019–2023 · strength 0.73
  4. Shinji Tanaka · 5 shared papers, 2020–2023 · strength 0.65
  5. Marco Del Chiaro · 3 shared papers, 2021–2023 · strength 0.45
  6. Daisuke Ban · 4 shared papers, 2019–2021 · strength 0.42
  7. Yoshiki Murase · 3 shared papers, 2020–2023 · strength 0.37
  8. Daisuke Asano · 2 shared papers, 2023 · strength 0.31
  9. Miles Piper · 2 shared papers, 2022–2023 · strength 0.30
  10. Sana D. Karam · 2 shared papers, 2022–2023 · strength 0.30
  11. Tomotaka Kato · 2 shared papers, 2021–2023 · strength 0.27
  12. Richard David Schulick · 2 shared papers, 2021–2022 · strength 0.26
  13. Aya Maekawa · 2 shared papers, 2020–2021 · strength 0.22
  14. Toshiro Ogura · 2 shared papers, 2019–2021 · strength 0.20
  15. Ayano Kabashima · 1 shared paper, 2023 · strength 0.16
  16. Takeshi Ishii · 1 shared paper, 2023 · strength 0.16
  17. Ronggui Lin · 1 shared paper, 2021 · strength 0.15
  18. Y. H. Andrew Wu · 1 shared paper, 2021 · strength 0.15
  19. Atsushi Oba · 1 shared paper, 2021 · strength 0.15
  20. Matthew H. G. Katz · 1 shared paper, 2024 · strength 0.13
  21. Floortje van Oosten · 1 shared paper, 2024 · strength 0.13
  22. Nader N Hanna · 1 shared paper, 2024 · strength 0.13
  23. Chanjuan Shi · 1 shared paper, 2024 · strength 0.13
  24. Myrte Gorris · 1 shared paper, 2024 · strength 0.13
  25. Lily V. Saadat · 1 shared paper, 2024 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.